Tech
Transfer
Summit

Paris, France
6-7 October 2008

at EuroBiO 2008

Cordis

Pharma Connections Worldwide

Keiretsu Forum

BioCentury

TII

Venture Valuation

UTEK

The Scientist

PharmaLicensing

EuroBiO 2008

London First

London Biotech Network

AUTM

European Private Equity & Venture Capital Association

Astra Zeneca

TVM Capital

Fasken Martineau

Neal Gerber Eisenberg

Boehringer Ingelheim

Johnson & Johnson

P&G

Pfizer

Paris Region Economic Development Agency

Accommodation

Tech Transfer Summit participants are advised to book accommodations early as both EuroBiO and the Paris Auto Show will be taking place in Paris during the same week as the Tech Transfer Summit.

The following hotels are recommended.  Bookings can be made directly with the hotels at the numbers listed below, or using online reservations services such as http://www.expedia.com or http://www.lastminute.com , and additional online help can be found at Paris Info at http://www.parisinfo.com

4 STAR HOTELS
3 STAR HOTELS
2 STAR HOTELS

 

Registration

Registration for the Tech Transfer Summit includes all of the following

Registration fees have been kept as low as possible to ensure access to all key stakeholders in the Tech Transfer process.  Places are strictly limited so register now!

Registration fees are  

Those participants wishing to participate in the partnering sessions of the EuroBiO meeting (http://www.eurobio2008.com) on October 8 & 9, following the Tech Transfer Summit (October 6 & 7) may register for EuroBioPartnerning at the reduced rates of

  • EUR 150 for Academic of Non-Profit
  • EUR 250 for Start-ups
  • Eur 350 for Industry, Finance, Legal & Consulting

Delegates are requested to view the EuroBio website in deciding whether or not to opt for this additional registration.

Speakers

TTS Speakers Confirmed to date

Sponsors & Partners

Tech Transfer Summit Sponsors:

Why Sponsor the Tech Transfer Summit™? 

Download Sponsorship Information and Form

About The Tech Transfer Summit

The inaugural Tech Transfer Summit was held in 2007 as part of the European Federation of Biotechnology’s 13th European Congress of Biotechnology. It was founded in partnership between The European Federation of Biotechnology (EFB) and Tech Investor Ltd to meet an increasing need for a better understanding between all the stakeholders in the Biotechnology community on the critical need for efficient transfer of early innovative research to commercializable product technology. The Summit is Europe’s premier think-tank for Technology Transfer professionals, researchers, business angels, Government funding bodies, PE VC professionals, financiers and financial service providers and the legal profession. The Summit provides a networking platform for dissemination and deliberation of problems and solutions alike, available methods and processes and ultimately provides access to business resources that underpin the commercialization of innovative technology. The Summit is of importance to entrepreneurial researchers & innovators, University Tech Transfer Offices, research institutes, corporations, and investors alike, allowing them to successfully network, collaborate and form partnerships that can help drive forward innovative technologies to the commercial markets.

Vision

The creation of a network of technology transfer professionals, leading researchers and corporate biotechnology stakeholders to help commercialize the ever increasing amount of innovative biotechnology in our society.

Mission

The constructive deliberation and debate that the Summit provides, coupled with exclusive networking opportunities with key biotechnology stakeholders, will enable the process of technology transfer to become better understood and applied and subsequently deliver that which we all strive to achieve; the commercialization of biotechnological innovation.

Goals

EFB - The Voice of Science The European Federation of Biotechnology is the Voice of Science for the biotechnology community in Europe.  Europe’s largest and most inclusive biotechnology organization with over 235 Institutional and 6,000 personal members from around the world, the EFB was founded by leading European scientific and learned societies in 1978 to serve as the biotechnology community.

The aims of the EFB are to foster a positive environment for biotechnology and to enable biotechnology to serve its rightful role in society, by promoting research and innovation at the cutting edge of biotechnology and the beneficial application and utilization of science. EFB provides a forum for interdisciplinary and international cooperation between stakeholders from public research and industry, and works to improve scientific education and to facilitate an informed dialogue between scientists and the public.

Application for membership is open to Public and Private Companies, National Biotechnology Associations, Learned and Scientific Societies, Universities, Research Institutes, Scientific Foundations, Bio Regions, Science Parkers, and individuals active in the biotechnology sector. EFB keeps close contact with the national biotech communities and with the European Institutions.

About Tech Investor Tech Investor Ltd (http://www.tech-investor.com) operates within the Life Science, Biotechnology and Chemical Industry sectors. Consulting on business development and strategy, Tech Investor also organizes exclusive select business-focused events in partnership with organisations that provide stakeholders with unsurpassed access to business leaders, original relevant information, and expertise and knowledge in all aspects of the commercialization of technological innovation.  Tech Investor recognizes the increasingly multi-disciplinary nature of technology and the diverse interactions in both science and business, that are providing new innovation and investment opportunities at an unprecedented rate.  Tech Investor recognizes the importance of “the business of science” and the critical role this plays in successful commercialization.

Download the Programme (PDF) here

Tech Transfer, Value Creation, & the Utilisation of World Class Science

Go to the new: 24-25 September 2009 European Tech Transfer Summit site.

SEE THE FULL TTS PROGRAMME & SPEAKERS

Registration Closed. SOLD OUT!

Download the Keynote Presentations from the 2008 Tech Transfer Summit:

RICHARD U. RODRIGUEZ, Director, Division of Technology Development & Transfer Office of Technology Transfer, National Institutes of Health (NIH) USA

DR. RICHARD SEABROOK, Head of Business Development, The Wellcome Trust UK

The European Federation of Biotechnology’s Tech Transfer Summit™, organized in partnership with Tech Investor is the original pan-European technology transfer meeting. A pioneering initiative developed not just to foster talk, but to highlight best practices and lessons from the foremost practitioners of tech transfer worldwide and lead the way in providing a forum and platform for learning,  networking, partnering and cooperation.

With large corporations such as Big Pharma, Large Biotech and industrial-based companies in the chemical and agricultural industries looking to create and secure innovative deals with universities, research institutes and early-stage and emerging biotech companies, the community as a whole requires Technology Transfer initiatives like never before. In such a market, understanding, knowledge and important connections to deliver the transfer of valuable and sought-after technology is a pre-requisite. For scientists, universities and research institutes, there is also a responsibility to ensure that when publicly funded science generates world class results, this science is applied and society is able to benefit from it. Smart, effective approaches to tech transfer are crucial to the development of a Knowledge Based Bio Economy.

The Tech Transfer Summit™, created by the European Federation of Biotechnology and Tech Investor Ltd., is the leading event of its kind, pioneering the effort to ensure that world class innovation is applied and brought to the market or society. It’s about utilising science & innovation rather than leaving it to sit on the shelf. Bringing together academia, industry and CEO entrepreneurs with leading international experts and practitioners in technology transfer, IP and licensing, the Tech Transfer Summit™ provides an un-matched environment for fostering increased and improved technology transfer, making sure that the true potential of world-class research is achieved.

The Tech Transfer Summit™  will be held in Paris, France on 6 - 7 October 2008 at EuroBiO 2008 at the Porte Maillot Palais des Congrès.

www.efb-central.org/tts

For a limited number of exclusive sponsorship opportunities please contact the Secretary General of EFB at .(JavaScript must be enabled to view this email address)